Share Prices & Company Research

Stockbroking

Astrazeneca

Current Price 7690.00p Bid 7690.00p Ask 7691.00p Change 1.53%
Last Updated: 21/02/2020 22:46. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

AstraZeneca plc is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular & Metabolic Diseases and Respiratory. The Company also is selectively active in the areas of autoimmunity, neuroscience and infection. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.

Financial Highlights Year Ended 31/12/2019

Turnover
£24,384.00m
Operating Profit
£2,924.00m
Dividend Yield
2.87
Dividend Per Share
218.30
Dividend Cover
0.47
P/E Ratio
73.93

Key Personnel

Pascal Claude Roland Soriot
Chief Executive Officer
Marc Pierre Jean Dunoyer
Chief Financial Officer
Leif Valdemar Johansson
Non-Executive Chairman
Sherilyn Dawn McCoy
Non-Executive Director
Tony Shu Kam Mok
Non-Executive Director
Prof Sabera Nazneen Rahman
Non-Executive Director
Marcus Wallenberg
Non-Executive Director
Michel Roger Demaré
Non-Executive Director
Deborah DiSanzo
Non-Executive Director
Graham Andrew Chipchase
Non-Executive Director
Philip Arthur John Broadley
Non-Executive Director
Prof Geneviève Bernadette Berger
Non-Executive Director

Stock Details

EPIC
AZN
ISIN
GB0009895292
Shares in Issue
1,312,187,447
Market cap
£99,923.07m

Analyst Views (13)

Strong Buy
 
61.54%
Buy
 
7.69%
Hold
 
15.38%
Sell
 
7.69%
Strong Sell
 
7.69%
The above information represents a selection of the views published in the last 120 days by analysts. It is subject to change without notice and doesn't reflect view held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
7690.00p
Bid Price
7690.00p
Ask Price
7691.00p
Volume
2008291
Change Today
116.00p
% Change Today
1.53%
Open
7585.00p
Previous Close
7690.00p
Intraday High
7773.00p
Intraday Low
7540.00p
52 Week High
7948.00p
52 Week Low
5626.00p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

Astrazeneca Intra-day Chart

Astrazeneca News

News in this section is provided by AJ Bell

Director Deals - AstraZeneca PLC (AZN) 19 Feb 2020 | 09:00 Broker Forecast - Kepler Cheuvreux issues a broker note on AstraZeneca PLC 18 Feb 2020 | 10:10 FTSE falls at the close but mid caps stage domestics rally 14 Feb 2020 | 17:36 FTSE rallies back into the black at midday as investors shrug off RBS challenges 14 Feb 2020 | 12:11 UK stocks open 0.4% lower as RBS warns of 'income challenges' 14 Feb 2020 | 08:31 AstraZeneca profit falls 22% as selling costs offset rising revenue 14 Feb 2020 | 07:27 UK stocks close sharply down 27 Jan 2020 | 16:36 UK stocks remain under pressure at midday 27 Jan 2020 | 13:05 FTSE opens 1.5% lower as coronavirus death toll rises to 81 27 Jan 2020 | 09:01 AstraZeneca sells rights to hypertension drugs; recovers rights to Crohn's disease drug 27 Jan 2020 | 07:32 AstraZeneca gastric cancer and stroke drugs meet primary goals 27 Jan 2020 | 07:21 Broker Forecast - Liberum Capital issues a broker note on AstraZeneca PLC 22 Jan 2020 | 08:00 AstraZeneca cancer treatments gets US orphan drug designation 20 Jan 2020 | 07:27 Broker Forecast - Credit Suisse issues a broker note on AstraZeneca PLC 16 Jan 2020 | 09:20 Broker Forecast - Barclays Capital issues a broker note on AstraZeneca PLC 16 Jan 2020 | 08:20 AstraZeneca cancer drug application granted priority review in US; ends heart disease trial 13 Jan 2020 | 07:17 FTSE closes in the red as Iran tensions escalation spooks investors, sparking oil and gold rallies 06 Jan 2020 | 17:01 Broker Forecast - Morgan Stanley issues a broker note on AstraZeneca PLC 06 Jan 2020 | 12:10 Escalating Iran tensions prompt oil price spike and drag FTSE into the red at midday 06 Jan 2020 | 11:55 Broker Forecast - JP Morgan Cazenove issues a broker note on AstraZeneca PLC 06 Jan 2020 | 10:20 FTSE falls in early trading as Iran tensions soar 06 Jan 2020 | 09:31 AstraZeneca hyperkalaemia drug approved in China; diabetes drug granted priority review in US 06 Jan 2020 | 07:21 UK stocks fall on slow trading day 30 Dec 2019 | 16:47 FTSE falls further on lack of newsflow 30 Dec 2019 | 11:58 UK stocks open 0.2% lower after strong December run 30 Dec 2019 | 09:01 AstraZeneca, Merck pancreatic cancer treatment approved in US 30 Dec 2019 | 07:06 UK stocks open 0.2% lower, capping two weeks of gains 23 Dec 2019 | 09:06 AstraZeneca respiratory disease treatment approved for use in China 23 Dec 2019 | 07:12 UK stocks open 0.2% higher as investors eye vote on Brexit deal 20 Dec 2019 | 08:59 AstraZeneca sells cancer treatment rights to Juvise Pharmaceuticals for up to $198m 20 Dec 2019 | 07:07

Assets (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2019
31 Dec 2018
Tangible Assets
7,688.0
7,421.0
Intangible Assets & Goodwill
33,148.0
33,666.0
Investments & Other Non-Current Assets
4,978.0
3,973.0
Total Non-Current Assets
45,814.0
45,060.0
Inventory
3,193.0
2,890.0
Trade & Receivables
5,761.0
5,574.0
Cash & Receivables
5,369.0
4,831.0
Other Current Assets & Assets Held for Resale
1,240.0
2,296.0
Total Assets
61,377.0
60,651.0

Liabilities (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2019
31 Dec 2018
Short Term Liabilities
18,117.0
16,292.0
Long Term Liabilities
28,664.0
30,315.0
Other Liabilities / Pension etc
0.0
0.0
Total Liabilities
46,781.0
46,607.0

Net Assets (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2019
31 Dec 2018
Net Assets
14,596.0
14,044.0

Equity (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2019
31 Dec 2018
Share Capital
328.0
317.0
Minority Interests
1,469.0
1,576.0
Retained Earnings
2,812.0
5,683.0
Share Premium Account
7,941.0
4,427.0
Other Equity
2,046.0
2,041.0
Total Equity
14,596.0
14,044.0

Cashflow (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2019
31 Dec 2018
Cashflow from Operating Activities
2,969.0
2,618.0
Cashflow Before Financing
2,312.0
3,581.0
Increase / Decrease in Cash
547.0
1,537.0

Income (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2019
31 Dec 2018
Turnover
24,384.0
22,090.0
Cost of Sales
4,921.0
4,936.0
Gross Profit
19,463.0
17,154.0
Operating Profit
2,924.0
3,387.0
Pre-Tax Profit
1,548.0
1,993.0
Profit / Loss for the Year
1,227.0
2,050.0

Dividend History

Data has been provided by AJ Bell

Period
Ex-Dividend Date
Payment Date
H2 Dividend
27 Feb 2020
30 Mar 2020
H1 Dividend
08 Aug 2019
09 Sep 2019
H2 Dividend
28 Feb 2019
27 Mar 2019
H1 Dividend
09 Aug 2018
10 Sep 2018
H2 Dividend
15 Feb 2018
19 Mar 2018
H1 Dividend
10 Aug 2017
11 Sep 2017
H2 Dividend
16 Feb 2017
20 Mar 2017
H1 Dividend
11 Aug 2016
12 Sep 2016
H2 Dividend
18 Feb 2016
21 Mar 2016
H1 Dividend
13 Aug 2015
14 Sep 2015
H2 Dividend
19 Feb 2015
23 Mar 2015
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.